Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line

Journal of Lipid Research

Volumn 57, Issue 11, 2016, Pages 2028-2039

  Podbielska, Maria ^a,b   Szulc, Zdzisław M ^a   Kurowska, Ewa ^b   Hogan, Edward L ^a   Bielawski, Jacek ^a   Bielawska, Alicja ^a   Bhat, Narayan R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Cell signaling; Lipidomics; Multiple sclerosis; Oligodendrocyte; Sphingolipids; Vesicles

Indexed keywords

CERAMIDE; CYTOKINE; GAMMA INTERFERON; SPHINGOLIPID; TUMOR NECROSIS FACTOR;

ARTICLE; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY TEST; EXOSOME; GLIOMA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; LIPID ANALYSIS; OLIGODENDROCYTE CULTURE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; TANDEM MASS SPECTROMETRY; TH1 CELL; TIME FACTOR; CHEMISTRY; GENETICS; METABOLISM; OLIGODENDROGLIA; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE;

CELL DEATH; CELL LINE, TUMOR; CERAMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; INTERFERON-GAMMA; OLIGODENDROGLIA; OLIGODENDROGLIOMA; SPHINGOLIPIDS; TANDEM MASS SPECTROMETRY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84993982045     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M070664     Document Type: Article

References (55)

1. Suk, K., S. Kim, Y. H. Kim, K. A. Kim, I. Chang, H. Yagita, M. Shong, and M. S. Lee. 2001. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J. Immunol. 166: 4481-4489.
2. Barthson, J., C. M. Germano, F. Moore, A. Maida, D. J. Drucker, P. Marchetti, C. Gysemans, C. Mathieu, G. Nunez, A. Jurisicova, et al. 2011. Cytokines tumor necrosis factor-alpha and interferon-gamma induce pancreatic beta-cell apoptosis through STAT1-mediated Bim protein activation. J. Biol. Chem. 286: 39632-39643.
3. Kiaer, C., and P. Thams. 2009. Serum albumin protects from cytokine-induced pancreatic beta cell death by a phosphoinositide 3-kinase-dependent mechanism. Endocrine. 35: 325-332.
4. Sasagawa, T., M. Hlaing, and T. Akaike. 2000. Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-gamma and TNF-alpha. Biochem. Biophys. Res. Commun. 272: 674-680.
5. Kamachi, M., A. Kawakami, S. Yamasaki, A. Hida, T. Nakashima, H. Nakamura, H. Ida, M. Furuyama, K. Nakashima, K. Shibatomi, et al. 2002. Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor alpha and interferon gamma. J. Lab. Clin. Med. 139: 13-19.
6. Takuma, T., K. Takeda, and K. Konno. 1987. Synergism of tumor necrosis factor and interferon-gamma in induction of differentiation of human myeloblastic leukemic ML-1 cells. Biochem. Biophys. Res. Commun. 145: 514-521.
7. Craig, R. W., and H. L. Buchan. 1989. Differentiation-inducing and cytotoxic effects of tumor necrosis factor and interferon-gamma in myeloblastic ML-1 cells. J. Cell. Physiol. 141: 46-52.
8. Andrews, T., P. Zhang, and N. R. Bhat. 1998. TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. J. Neurosci. Res. 54: 574-583.
9. Buntinx, M., M. Moreels, F. Vandenabeele, I. Lambrichts, J. Raus, P. Steels, P. Stinissen, and M. Ameloot. 2004. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J. Neurosci. Res. 76: 834-845.
10. Testai, F. D., M. A. Landek, and G. Dawson. 2004. Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. J. Neurosci. Res. 75: 66-74.
11. Scurlock, B., and G. Dawson. 1999. Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J. Neurosci. Res. 55: 514-522.
12. Buntinx, M., E. Gielen, P. Van Hummelen, J. Raus, M. Ameloot, P. Steels, and P. Stinissen. 2004. Cytokine-induced cell death in human oligodendroglial cell lines. II: alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J. Neurosci. Res. 76: 846-861.
13. Larocca, J. N., M. Farooq, and W. T. Norton. 1997. Induction of oligodendrocyte apoptosis by C2-ceramide. Neurochem. Res. 22: 529-534.
14. Haimovitz-Friedman, A., R. N. Kolesnick, and Z. Fuks. 1997. Ceramide signaling in apoptosis. Br. Med. Bull. 53: 539-553.
15. Lee, J. T., J. Xu, J. M. Lee, G. Ku, X. Han, D. I. Yang, S. Chen, and C. Y. Hsu. 2004. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164: 123-131.
16. Jana, A., E. L. Hogan, and K. Pahan. 2009. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J. Neurol. Sci. 278: 5-15.
17. Novgorodov, S. A., D. A. Chudakova, B. W. Wheeler, J. Bielawski, M. S. Kindy, L. M. Obeid, and T. I. Gudz. 2011. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis. J. Biol. Chem. 286: 4644-4658.
18. Yoon, S. O., P. Casaccia-Bonnefil, B. Carter, and M. V. Chao. 1998. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J. Neurosci. 18: 3273-3281.
19. Ge, R., E. Tan, S. Sharghi-Namini, and H. H. Asada. 2012. Exosomes in cancer microenvironment and beyond: have we overlooked these extracellular messengers? Cancer Microenviron. 5: 323-332.
20. Kowal, J., M. Tkach, and C. Thery. 2014. Biogenesis and secretion of exosomes. Curr. Opin. Cell Biol. 29: 116-125.
21. Raposo, G., and W. Stoorvogel. 2013. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200: 373-383.
22. Colombo, M., G. Raposo, and C. Thery. 2014. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30: 255-289.
23. Simons, M., and G. Raposo. 2009. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21: 575-581.
24. Bobrie, A., M. Colombo, G. Raposo, and C. Thery. 2011. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 12: 1659-1668.
25. Trajkovic, K., C. Hsu, S. Chiantia, L. Rajendran, D. Wenzel, F. Wieland, P. Schwille, B. Brugger, and M. Simons. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 319: 1244-1247.
26. Simons, M., and K. Trajkovic. 2006. Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J. Cell Sci. 119: 4381-4389.
27. Trajkovic, K., A. S. Dhaunchak, J. T. Goncalves, D. Wenzel, A. Schneider, G. Bunt, K. A. Nave, and M. Simons. 2006. Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites. J. Cell Biol. 172: 937-948.
28. Frühbeis, C., D. Fröhlich, and E. M. Krämer-Albers. 2012. Emerging roles of exosomes in neuron-glia communication. Front. Physiol. 3: 119.
29. Turola, E., R. Furlan, F. Bianco, M. Matteoli, and C. Verderio. 2012. Microglial microvesicle secretion and intercellular signaling. Front. Physiol. 3: 149.
30. Robbins, P. D., and A. E. Morelli. 2014. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14: 195-208.
31. Candelario, K. M., and D. A. Steindler. 2014. The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends Mol. Med. 20: 368-374.
32. Record, M., K. Carayon, M. Poirot, and S. Silvente-Poirot. 2014. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim. Biophys. Acta. 1841: 108-120.
33. Buzas, E. I., B. Gyorgy, G. Nagy, A. Falus, and S. Gay. 2014. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol. 10: 356-364.
34. Chen, W. X., X. M. Liu, M. M. Lv, L. Chen, J. H. Zhao, S. L. Zhong, M. H. Ji, Q. Hu, Z. Luo, J. Z. Wu, et al. 2014. Exosomes from drugresistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One. 9: e95240.
35. Rajendran, L., J. Bali, M. M. Barr, F. A. Court, E. M. Kramer-Albers, F. Picou, G. Raposo, K. E. van der Vos, G. van Niel, J. Wang, et al. 2014. Emerging roles of extracellular vesicles in the nervous system. J. Neurosci. 34: 15482-15489.
36. Post, G. R., and G. Dawson. 1992. Characterization of a cell line derived from a human oligodendroglioma. Mol. Chem. Neuropathol. 16: 303-317.
37. Bakhti, M., C. Winter, and M. Simons. 2011. Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosomelike vesicles. J. Biol. Chem. 286: 787-796.
38. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
39. Bielawski, J., J. S. Pierce, J. Snider, B. Rembiesa, Z. M. Szulc, and A. Bielawska. 2009. Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol. Biol. 579: 443-467.
40. Bielawski, J., J. S. Pierce, J. Snider, B. Rembiesa, Z. M. Szulc, and A. Bielawska. 2010. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Adv. Exp. Med. Biol. 688: 46-59.
41. Krysko, D. V., T. Vanden Berghe, K. D'Herde, and P. Vandenabeele. 2008. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods. 44: 205-221.
42. Li, R. X., and S. Ladisch. 1991. Shedding of human neuroblastoma gangliosides. Biochim. Biophys. Acta. 1083: 57-64.
43. Kjellberg, M. A., M. Lonnfors, J. P. Slotte, and P. Mattjus. 2015. Metabolic conversion of ceramides in HeLa cells - a cholesteryl phosphocholine delivery approach. PLoS One. 10: e0143385.
44. Qin, J., E. Berdyshev, J. Goya, V. Natarajan, and G. Dawson. 2010. Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis. J. Biol. Chem. 285: 14134-14143.
45. Kim, S., A. J. Steelman, Y. Zhang, H. C. Kinney, and J. Li. 2012. Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury. Brain Pathol. 22: 41-57.
46. Osawa, Y., H. Uchinami, J. Bielawski, R. F. Schwabe, Y. A. Hannun, and D. A. Brenner. 2005. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J. Biol. Chem. 280: 27879-27887.
47. White-Gilbertson, S., T. Mullen, C. Senkal, P. Lu, B. Ogretmen, L. Obeid, and C. Voelkel-Johnson. 2009. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene. 28: 1132-1141.
48. D'Agostino, S., M. Salamone, I. Di Liegro, and M. L. Vittorelli. 2006. Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis. Int. J. Oncol. 29: 1075-1085.
49. Merrill, A. H., Jr. 2011. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111: 6387-6422.
50. Mencarelli, C., and P. Martinez-Martinez. 2013. Ceramide function in the brain: when a slight tilt is enough. Cell. Mol. Life Sci. 70: 181-203.
51. Wheeler, D., V. V. Bandaru, P. A. Calabresi, A. Nath, and N. J. Haughey. 2008. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain. 131: 3092-3102.
52. Vidaurre, O. G., J. D. Haines, I. Katz Sand, K. P. Adula, J. L. Huynh, C. A. McGraw, F. Zhang, M. Varghese, E. Sotirchos, P. Bhargava, et al. 2014. Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain. 137: 2271-2286.
53. Mathivanan, S., and R. J. Simpson. 2009. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics. 9: 4997-5000.
54. Mathivanan, S., C. J. Fahner, G. E. Reid, and R. J. Simpson. 2012. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 40: D1241-D1244.
55. Lakhal, S., and M. J. Wood. 2011. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. BioEssays. 33: 737-741.